US 11584758
RIP1K inhibitors
granted A61KA61K9/0053A61P
Quick answer
US patent 11584758 (RIP1K inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K9/0053, A61P, A61P17/00, A61P25/00